Literature DB >> 26185207

Novel Role of miR-33 in Regulating of Mitochondrial Function.

Nathan L Price1, Carlos Fernández-Hernando2.   

Abstract

Entities:  

Keywords:  adenosine triphosphate; atherosclerosis; foam cells; miR-33; plaque, atherosclerotic

Mesh:

Substances:

Year:  2015        PMID: 26185207      PMCID: PMC4643669          DOI: 10.1161/CIRCRESAHA.117.306949

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  22 in total

1.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

2.  Mitochondrial (dys)function and regulation of macrophage cholesterol efflux.

Authors:  Anne Marie Allen; Janice M W Taylor; Annette Graham
Journal:  Clin Sci (Lond)       Date:  2013-04       Impact factor: 6.124

3.  Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.

Authors:  Veerle Rottiers; Susanna Obad; Andreas Petri; Robert McGarrah; Marie W Lindholm; Joshua C Black; Sumita Sinha; Robin J Goody; Matthew S Lawrence; Andrew S deLemos; Henrik F Hansen; Steve Whittaker; Steve Henry; Rohn Brookes; S Hani Najafi-Shoushtari; Raymond T Chung; Johnathan R Whetstine; Robert E Gerszten; Sakari Kauppinen; Anders M Näär
Journal:  Sci Transl Med       Date:  2013-11-20       Impact factor: 17.956

4.  Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice.

Authors:  Tiangang Li; Jessica M Francl; Shannon Boehme; John Y L Chiang
Journal:  Hepatology       Date:  2013-07-31       Impact factor: 17.425

5.  MicroRNA 33 regulates glucose metabolism.

Authors:  Cristina M Ramírez; Leigh Goedeke; Noemi Rotllan; Je-Hyun Yoon; Daniel Cirera-Salinas; Julie A Mattison; Yajaira Suárez; Rafael de Cabo; Myriam Gorospe; Carlos Fernández-Hernando
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

6.  Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.

Authors:  Noemi Rotllan; Cristina M Ramírez; Binod Aryal; Christine C Esau; Carlos Fernández-Hernando
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-23       Impact factor: 8.311

7.  SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function.

Authors:  Nathan L Price; Ana P Gomes; Alvin J Y Ling; Filipe V Duarte; Alejandro Martin-Montalvo; Brian J North; Beamon Agarwal; Lan Ye; Giorgio Ramadori; Joao S Teodoro; Basil P Hubbard; Ana T Varela; James G Davis; Behzad Varamini; Angela Hafner; Ruin Moaddel; Anabela P Rolo; Roberto Coppari; Carlos M Palmeira; Rafael de Cabo; Joseph A Baur; David A Sinclair
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

8.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Authors:  Katey J Rayner; Christine C Esau; Farah N Hussain; Allison L McDaniel; Stephanie M Marshall; Janine M van Gils; Tathagat D Ray; Frederick J Sheedy; Leigh Goedeke; Xueqing Liu; Oleg G Khatsenko; Vivek Kaimal; Cynthia J Lees; Carlos Fernandez-Hernando; Edward A Fisher; Ryan E Temel; Kathryn J Moore
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

9.  Mitochondrial function is involved in regulation of cholesterol efflux to apolipoprotein (apo)A-I from murine RAW 264.7 macrophages.

Authors:  Anne Marie Allen; Annette Graham
Journal:  Lipids Health Dis       Date:  2012-12-10       Impact factor: 3.876

10.  MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.

Authors:  Takahiro Horie; Tomohiro Nishino; Osamu Baba; Yasuhide Kuwabara; Tetsushi Nakao; Masataka Nishiga; Shunsuke Usami; Masayasu Izuhara; Naoya Sowa; Naoya Yahagi; Hitoshi Shimano; Shigenobu Matsumura; Kazuo Inoue; Hiroyuki Marusawa; Tomoyuki Nakamura; Koji Hasegawa; Noriaki Kume; Masayuki Yokode; Toru Kita; Takeshi Kimura; Koh Ono
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  6 in total

1.  Experimental Study on the Compatibility and Characteristics of a Dual-Target Microbubble Loaded with Anti-miR-33.

Authors:  Chen Yuan; Yanhong Li; Liyun Liu; Baihetiya Tayier; Lingjie Yang; Lina Guan; Yuming Mu
Journal:  Int J Nanomedicine       Date:  2021-09-11

2.  Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis.

Authors:  Gantsetseg Tumurkhuu; Kenichi Shimada; Jargalsaikhan Dagvadorj; Timothy R Crother; Wenxuan Zhang; Daniel Luthringer; Roberta A Gottlieb; Shuang Chen; Moshe Arditi
Journal:  Circ Res       Date:  2016-07-06       Impact factor: 17.367

3.  MicroRNA-33/33* inhibit the activation of MAVS through AMPK in antiviral innate immunity.

Authors:  Danhui Liu; Qinchun Tan; Jie Zhu; Yuanyuan Zhang; Yue Xue; Yinjing Song; Yang Liu; Qingqing Wang; Lihua Lai
Journal:  Cell Mol Immunol       Date:  2019-11-25       Impact factor: 22.096

4.  MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation.

Authors:  Viviana Costa; Valeria Carina; Lavinia Raimondi; Angela De Luca; Daniele Bellavia; Alice Conigliaro; Francesca Salamanna; Riccardo Alessandro; Milena Fini; Gianluca Giavaresi
Journal:  Cells       Date:  2019-11-22       Impact factor: 6.600

5.  Osteoblast-targeted delivery of miR-33-5p attenuates osteopenia development induced by mechanical unloading in mice.

Authors:  Han Wang; Zebing Hu; Fei Shi; Jingjing Dong; Lei Dang; Yixuan Wang; Zhongyang Sun; Hua Zhou; Shu Zhang; Xinsheng Cao; Ge Zhang
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

Review 6.  Novel Insights in the Metabolic Syndrome-induced Oxidative Stress and Inflammation-mediated Atherosclerosis.

Authors:  Johnna F Varghese; Rohit Patel; Umesh C S Yadav
Journal:  Curr Cardiol Rev       Date:  2018-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.